Table 1.
Types of EMNMs | Movement mechanism | Materials | Fuel | Motion environment | Motion speed | Application | Schematic diagram | Ref | ||
---|---|---|---|---|---|---|---|---|---|---|
Molecule motors and enzymes as motors | Synthesis and decomposition of ATP | Myosin, dynein and kinesin | ATP | – | – | – | 16,17,18 | |||
Synthesis and decomposition of ATP | ATP synthase | ATP | – | – | – | 20 | ||||
Enzyme-enhanced diffusion | Urease | Urea | Water | – | – | 24 | ||||
Enzyme-enhanced diffusion | DNA polymerase | Nucleotide | Buffer solution | – | Micro/nanopump | 26 | ||||
Single enzymatic reaction propelled EMNMs | Catalase | Bubbles propulsion | Ti/Au film | H2O2 | Water | 226.1 ± 21.1 μm/s in 1.5% H2O2 | – | 28 | ||
Bubbles propulsion | Fpoly(ethylene glycol) diacrylate and dextran | H2O2 | Water | 102.96 ± 2.08 μm/s in 4% H2O2 | – | 32 | ||||
Bubbles propulsion | Mesoporous silica | H2O2 | Water | – | Drug delivery | 34 | ||||
Bubbles propulsion | Organoclay/DNA semipermeable microcapsules | H2O2 | Water | – | Motor functionalization | 36 | ||||
Bubbles propulsion | Biotinylated polymer vesicles | H2O2 | Water | – | Biomedical application | 39 | ||||
Bubbles propulsion | Bovine serum albumin/poly- l-lysine (PLL/BSA) multilayer | H2O2 | PBS solution | 68 μm/s in 0.5% H2O2 |
Drug delivery | 112 | ||||
Bubbles propulsion | Polymer capsules | H2O2 | – | 232 μm/s in 2% H2O2 | Drug delivery | 96 | ||||
Bubbles propulsion | Janus Au–mesoporous silica | H2O2 | PBS solution | – | Drug delivery | 113 | ||||
Bubbles propulsion | Metal–organic frameworks | H2O2 | – | – | Drug delivery | 37 | ||||
Bubbles propulsion | Polymersomes | H2O2 | – | – | Drug delivery | 33 | ||||
Bubbles propulsion | Polymer based bottlebrush | H2O2 | a viscous tumor microenvironment gel model |
– | Overcoming tissue penetration barrier | 35 | ||||
Bubbles propulsion | PEDOT/Au bilayer microtubes | H2O2 | Water | 54.0 ± 3.5 μm/s in 2% H2O2 |
Biochemical sensing | 29 | ||||
Bubbles propulsion | PEDOT/Au bilayer microtubes | H2O2 | Water | 380 μm/s in 2% H2O2 |
Biochemical sensing | 120 | ||||
Bubbles propulsion | PEDOT/Au microtubes | H2O2 | Water | 411 ± 40 μm/s in 5% H2O2 |
Biochemical sensing | 124 | ||||
Bubbles propulsion | PEDOT-PSS/Au microtubes | H2O2 | Water | ~51 μm/s in 0.25% H2O2 |
Biochemical sensing | 30 | ||||
Bubbles propulsion | Multi-metallic (Au/Ag/Ni/Au) | H2O2 | Water | ~209 μm/s in 1.5% H2O2 | Biochemical sensing | 95 | ||||
Bubbles propulsion | Iron oxide particles | H2O2 | Water | – | Biochemical sensing | 125 | ||||
Bubbles propulsion | PSMA/PS mixtures | H2O2 | PBS solution | 19–69 μm/s in 3.5% H2O2 | Biochemical sensing | 127 | ||||
Bubbles propulsion | Silk fibroin | H2O2 | – | – | Microstirrers | 131 | ||||
Bubbles propulsion | Plant tissues | H2O2 | Water | – | Environmental remediation | 41 | ||||
Urease | Phoretic propulsion | Silica | Urea | Water | ~5.25 μm/s in 0.1 mol/L urea | Biomedical application | 42 | |||
Phoretic propulsion | Mesoporous silica | Urea | Water | ~8 μm/s in 0.05 mol/L urea | Drug delivery | 15 | ||||
Phoretic propulsion | Protein | Urea | PB solution | 2.7 ± 0.2 μm/s in 0.1 mol/L urea | Biomedical application | 45 | ||||
Phoretic propulsion | Mesoporous silica | Urea | Water and ionic media | – | Drug delivery | 43 | ||||
Phoretic propulsion | Mesoporous silica | Urea | Water and PBS | – | Drug delivery | 44 | ||||
Phoretic propulsion | Mesoporous silica | Urea | Urine | – | Targeted bladder cancer therapy | 117 | ||||
Phoretic propulsion | Platelet cell | Urea | PBS solution | – | Drug delivery | 118 | ||||
Phoretic propulsion | Mesoporous silica | Urea | Ficoll solutions | – | Drug delivery | 119 | ||||
Phoretic propulsion | Mesoporous SiO2 | Urea | Water | 6.49 μm/s in 0.05 mol/L urea solution | Photodynamic therapy | 90 | ||||
Phoretic propulsion | Mesoporous silica | Urea | PBS solution | – | Biochemical sensing | 126 | ||||
Other enzymes | ATPase | Phoretic propulsion | Phospholipid vesicles | ATP | Buffer solution | – | – | 48 | ||
Nicking enzyme | Nicking enzyme that cuts tracks | DNA and restriction enzyme | – | – | 0.1 nm/s | – | 51 | |||
RNase H | Hydrolysis of hybridized RNA | DNA and RNA | RNase H | – | – | – | 52 | |||
Lipase | – | Mesoporous silica | triacetin | PBS solution | – | Environmental remediation | 50 | |||
GOx-Cat | Bubbles propulsion | Asymmetric polymersome | Glucose | – | – | Drug delivery | 116 | |||
Catalase, urease, lipase, GOx | – | – | H2O2, Urea, Glucose |
– | – | Micropumps | 128 | |||
Multiple enzymes | GOx bilirubin oxidase | Electrophoresis | Carbon fiber | Glucose | Buffer solution | ~1 cm/s in 0.01 mol/L glucose | – | 53 | ||
GOx and catalase | Bubbles propulsion | Carbon nanotubes | Glucose | Water | – | – | 55 | |||
GOx and catalase | Bubbles propulsion | Colloids | Glucose | Buffer solution | – | Drug delivery | 56 | |||
GOx and catalase | Bubbles propulsion | Polymer | Glucose | – | ~11 μm/s in 0.01 mol/L glucose | Drug delivery | 57 | |||
GOx and catalase | Bubbles propulsion | Polymer | Glucose | – | – | – | 58 | |||
GOx and catalase | Bubbles propulsion | Metal–organic frameworks | Glucose | – | – | Photodynamic therapy | 59 | |||
GOx and catalase | Bubbles propulsion | Carbonization of L-CNF | Glucose | Water | ~0.4 μm/s in 0.01 mol/L glucose | – | 60 | |||
GOx and trypsin | Bubbles propulsion and phoretic propulsion | Inorganic substance | Glucose, BA-Rho-110 | Water | 0.72 μm/s in 0.4 mol/L glucose and 0.1 μmol/L BA-Rho-110 solution | – | 61 |